Sight Sciences, Inc.
Sight Sciences, Inc. (SGHT) Financial Performance & Income Statement Overview
Review Sight Sciences, Inc. (SGHT) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Sight Sciences, Inc. (SGHT) Income Statement & Financial Overview
View the income breakdown for Sight Sciences, Inc. SGHT across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $17.51M | $19.07M | $20.16M | $21.37M |
| Cost of Revenue | $2.41M | $2.51M | $3.25M | $3.02M |
| Gross Profit | $15.09M | $16.56M | $16.91M | $18.34M |
| Gross Profit Ratio | $0.86 | $0.87 | $0.84 | $0.86 |
| R&D Expenses | $4.43M | $4.29M | $4.75M | $4.32M |
| SG&A Expenses | $24.52M | $24.20M | $23.39M | $26.68M |
| Operating Expenses | $28.95M | $28.49M | $28.14M | $31.00M |
| Total Costs & Expenses | $31.37M | $31.003M | $31.39M | $34.02M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | -$1.26M | $1.16M | $1.15M | $1.15M |
| Depreciation & Amortization | $0.00 | $176000.00 | $158000.00 | $100000.00 |
| EBITDA | -$13.86M | -$10.47M | -$11.23M | -$11.07M |
| EBITDA Ratio | -$0.79 | -$0.55 | -$0.56 | -$0.52 |
| Operating Income | -$13.86M | -$11.93M | -$11.23M | -$12.65M |
| Operating Income Ratio | -$0.79 | -$0.63 | -$0.56 | -$0.59 |
| Other Income/Expenses (Net) | -$254000.00 | $121000.00 | $329000.00 | $337000.00 |
| Income Before Tax | -$14.11M | -$11.81M | -$10.90M | -$12.31M |
| Income Before Tax Ratio | -$0.81 | -$0.62 | -$0.54 | -$0.58 |
| Income Tax Expense | $41000.00 | $38000.00 | $166000.00 | $15000.00 |
| Net Income | -$14.15M | -$11.85M | -$11.07M | -$12.33M |
| Net Income Ratio | -$0.81 | -$0.62 | -$0.55 | -$0.58 |
| EPS | -$0.28 | -$0.24 | -$0.22 | -$0.25 |
| Diluted EPS | -$0.28 | -$0.24 | -$0.22 | -$0.25 |
| Weighted Avg Shares Outstanding | $51.29M | $50.80M | $50.34M | $49.90M |
| Weighted Avg Shares Outstanding (Diluted) | $51.29M | $50.80M | $50.34M | $49.90M |
Over the past four quarters, Sight Sciences, Inc. demonstrated steady revenue growth, increasing from $21.37M in Q2 2024 to $17.51M in Q1 2025. Operating income reached -$13.86M in Q1 2025, maintaining a consistent -79% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$13.86M, reflecting operational efficiency. Net income dropped to -$14.15M, with EPS at -$0.28. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan